Telmisartan increases systemic exposure to rosuvastatin after single and multiple doses, and in vitro studies show telmisartan inhibits ABCG2-mediated transport of rosuvastatin

Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events

The ONTARGET Investigators · New England Journal of Medicine · 2008 · 3.5K citations · Full text

Medicine, Cardiology, Pharmacotherapy +12

Identification of Telmisartan as a Unique Angiotensin II Receptor Antagonist With Selective PPARγ–Modulating Activity

Stephen C. Benson, Harrihar A. Pershadsingh, Christopher Ho et al. · Hypertension · 2004 · 1.1K citations

Medicine, Endocrinology, Pharmacology +17

PTEN/PI3K/Akt Pathway Regulates the Side Population Phenotype and ABCG2 Activity in Glioma Tumor Stem-like Cells

Anne-Marie Bleau, Dolores Hambardzumyan, Tatsuya Ozawa et al. · Cell stem cell · 2009 · 801 citations · Full text

Medicine, Cancer Biology, Oncology +17

Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment

Eminy H.Y. Lee, S RYAN, Bruce K. Birmingham et al. · Clinical Pharmacology & Therapeutics · 2005 · 477 citations

Medicine, Pharmacokinetics, Pharmacology +17

Genetic Determinants of Statin-Induced Low-Density Lipoprotein Cholesterol Reduction

Daniel I. Chasman, Franco Giulianini, Jean MacFadyen et al. · Circulation Cardiovascular Genetics · 2012 · 291 citations · Full text

Life Sciences, Genetics, Pharmacology +17